Table 3.
Group | n | HBsAg | Anti-HCV | Anti-HIV | |||
n (%) | n (%) | n (%) | |||||
Female | 3999 | 88 | (2.20) | 15 | (0.38) | 0 | (0) |
Male | 13546 | 343 | (2.53) | 65 | (0.48) | 0 | (0) |
Total | 17545 | 431 | (2.46) | 80 | (0.46) | 0 | (0) |
Group | n | HBsAg | Anti-HCV | Anti-HIV | |||
n (%) | n (%) | n (%) | |||||
Female | 3999 | 88 | (2.20) | 15 | (0.38) | 0 | (0) |
Male | 13546 | 343 | (2.53) | 65 | (0.48) | 0 | (0) |
Total | 17545 | 431 | (2.46) | 80 | (0.46) | 0 | (0) |